Eli Lily's stock went through record highs and Mounjaro's sales grew by 91 per cent

Eli Lily's stock was prominent in the competition with Novo Nordisk, breaking the flat base and making a record high. The company ' s Mounjaro drug sales increased by 91 per cent in the second quarter。